Cloud Banner

Healthcare

Image

Global DNA Fragmentation Technique Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global DNA Fragmentation Technique Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 11.899999999999999% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 5.89 Billion
Diagram Market Size (Forecast Year) USD 14.48 Billion
Diagram CAGR 11.899999999999999%

Global DNA Fragmentation Technique Market, By Treatment Type (Assisted Reproductive Technology and Varicocele Surgery, Medication), Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies), End User (Hospitals and Clinics, Fertility Centers, Research Institutes, Other End Users), Test Type (SCSA (Sperm Chromatin Structure Assay), TUNEL Assay, Halo Test, Comet Assay, Unexplained Infertility Treatment) – Industry Trends and Forecast to 2029

DNA Fragmentation Technique Market Analysis and Size

The market for DNA fragmentation technique is expected to grow during the forecast period. The most important factors fuelling the growth of the global market for advanced DNA fragmentation techniques include rising public awareness of the benefits and availability of these techniques, an increase in patients with lifestyle diseases and obesity, rising adoption of improved and more advanced assisted reproductive technologies, and a rise in the world's geriatric population.

Data Bridge Market Research analyses that the DNA fragmentation technique market which was USD 5.89 billion in 2021, would rocket up to USD 14.48 billion by 2029, and is expected to undergo a CAGR of 11.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment Type (Assisted Reproductive Technology and Varicocele Surgery, Medication), Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies), End User (Hospitals and Clinics, Fertility Centers, Research Institutes, Other End Users), Test Type (SCSA (Sperm Chromatin Structure Assay), TUNEL Assay, Halo Test, Comet Assay, Unexplained Infertility Treatment)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Merck KGaA (Germany), SCSA Diagnostics Inc. (U.S.), Halotech DNA (Spain), Vitrolife (Sweden), Cadila Pharmaceuticals (India), The Cooper Companies Inc. (U.S.), Cryolab Ltd (U.K.), Microm UK Ltd. (U.K.), Thermo Fisher Scientific Inc. (U.S.), COVARIS LLC (U.S.), SeqLL Inc. (U.S.), SCSA Diagnostics (U.S.)

Market Opportunities

  • Increase in the number of geriatric people
  • Rising infertility rate

Market Definition

The splitting or breaking of DNA strands into pieces is known as DNA fragmentation. Cells can do it on purpose, laboratory workers can do it on purpose, or it can happen naturally. DNA fragmentation that occurs accidentally or spontaneously builds up over time in a cell. It can be determined, for instance, using the Comet test or the TUNEL assay.

DNA Fragmentation Technique Market Dynamics

Drivers

  • Adoption of new technologies

Fragmentation of DNA is the first main step in preparing a sequencing library for NGS. The well-known NGS technologies such as Illumina or Ion Torrent generate a plethora of reads with lengths under 600–1000 bases.

Growing adoption of new and improved assisted reproductive technologies, an increase in the number of geriatric people around the world, and a rising infertility rate are some of the factors that are predicted to contribute to the growth of the DNA fragmentation technique market during the forecast period of 2022–2029. The market for DNA fragmentation techniques will expand during the forecast period due to rising medical tourism incidence and advanced technologies advancement.

  • Rise in public awareness

The most important factors fuelling the growth of the global market for advanced DNA fragmentation techniques include rising public awareness of the benefits and availability of these techniques, an increase in patients with lifestyle diseases and obesity, rising adoption of improved and more advanced assisted reproductive technologies, and a rise in the world's geriatric population.

Opportunities

The DNA fragmentation technique market's growth is fuelled by an increase in the number of research and development activities. This will provide beneficial opportunities for the DNA fragmentation technique market growth.

Moreover, an increase in the number of emerging markets and new product launches will further provide beneficial opportunities for the DNA fragmentation technique market growth during the forecast period.

Restraints/Challenges

On the other hand, societal issues and treatment discontinuation will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the DNA fragmentation technique market.

This DNA fragmentation technique market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the DNA fragmentation technique market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global DNA Fragmentation Technique Market Scope

The DNA fragmentation technique market is segmented on the basis of treatment type, distribution channel, test type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Type

  • Assisted Reproductive Technology
  •  Varicocele Surgery
  • Medication

 Distribution Channel

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

End User

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Other End Users

 Test Type

  • SCSA (Sperm Chromatin Structure Assay)
  • TUNEL Assay
  • Halo Test
  • Comet Assay
  • Unexplained Infertility Treatment

DNA Fragmentation Technique Market Regional Analysis/Insights

The DNA fragmentation technique market is analysed and market size insights and trends are provided by country, treatment type, distribution channel, test type and end user as referenced above.

The countries covered in the DNA fragmentation technique market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the DNA fragmentation technique market due to the prevalence of advanced and well-equipped fertility clinics along with rising awareness among the people.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing occurrences of lifestyle diseases along with rising geriatric population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and DNA Fragmentation Technique Market Share Analysis

The DNA fragmentation technique market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to DNA fragmentation technique market.

Some of the major players operating in the DNA fragmentation technique market are:

  • Merck KGaA (Germany)
  • SCSA Diagnostics Inc. (U.S.)
  • Halotech DNA (Spain)
  • Vitrolife (Sweden)
  • Cadila Pharmaceuticals (India)
  • The Cooper Companies Inc. (U.S.)
  • Cryolab Ltd (U.K.)
  • Microm UK Ltd. (U.K.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • COVARIS LLC (U.S.)
  • SeqLL Inc. (U.S.)
  • SCSA Diagnostics (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The DNA fragmentation technique market value is projected USD 14.48 billion by 2029.
The DNA Fragmentation Technique Market is to grow at a CAGR of 11.90% during the forecast by 2029.
The major players operating in the DNA Fragmentation Technique Market are Merck KGaA (Germany), SCSA Diagnostics Inc. (U.S.), Halotech DNA (Spain), Vitrolife (Sweden), Cadila Pharmaceuticals (India), The Cooper Companies Inc. (U.S.), Cryolab Ltd (U.K.), Microm UK Ltd. (U.K.), Thermo Fisher Scientific Inc. (U.S.), COVARIS LLC (U.S.), SeqLL Inc. (U.S.), SCSA Diagnostics (U.S.).
The key opportunities of the DNA Fragmentation Technique Market are Increase in the number of geriatric people, & Rising infertility rate.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials